Naltrexone hydrochloride (NTX) has been demonstrated to be beneficial as a pharmacological intervention for ME/CFS patients and experimental investigations have shown NTX restored TRPM3 function in NK cells. This evidence concerns the gene TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome.